Achilles Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$69,665,000 over the previous period. Total operating expenses were $75,255,000.
Profit Margin
| 2019 | 0 | -13.99M | |
|---|---|---|---|
| 2020 | 0 | -33.19M | |
| 2021 | 0 | -61.09M | |
| 2022 | 0 | -71.17M | |
| 2023 | 0 | -69.66M |
ACHL Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 4.73M | 3.68M | 3.28M | 778.00K | 303.25K |
Gross profit | -4.73M | -3.68M | -3.28M | -778.00K | -303.25K |
Operating exp. | |||||
Research and development | 67.64M | 57.26M | 42.22M | 22.62M | 9.07M |
Selling and marketing | -4.66M | 0 | 0 | 0 | 0 |
Total operating expenses | 75.25M | 78.38M | 64.19M | 33.72M | 13.77M |
Operating income | -75.25M | -78.38M | -64.19M | -33.72M | -13.77M |
Other income (expenses), net | 6.08M | 7.31M | 3.13M | 531K | -215K |
Income before tax | -69.17M | -71.06M | -61.06M | -33.19M | -13.99M |
Income tax expense | 491K | 111K | 37K | 3K | 0 |
Net income | -69.66M | -71.17M | -61.09M | -33.19M | -13.99M |
Earnings per share | |||||
Basic EPS | -1.74 | -1.82 | -2.13 | -0.82 | -8.52 |
Diluted EPS | -1.74 | -1.82 | -2.13 | -0.82 | -8.52 |
| Data source | Data source | Data source |